Effect of single dose of SA 14-14-2 vaccine 1 year after immunisation in Nepalese children with Japanese encephalitis: a case-control study.
about
Vaccines for preventing Japanese encephalitisProduct review on the JE vaccine IXIAROVaccine strategies for the control and prevention of Japanese encephalitis in Mainland China, 1951-2011Japanese encephalitis: the virus and vaccinesNew Japanese encephalitis vaccines: alternatives to production in mouse brain.Concomitant or sequential administration of live attenuated Japanese encephalitis chimeric virus vaccine and yellow fever 17D vaccine: randomized double-blind phase II evaluation of safety and immunogenicity.Genetic and phenotypic properties of vero cell-adapted Japanese encephalitis virus SA14-14-2 vaccine strain variants and a recombinant clone, which demonstrates attenuation and immunogenicity in mice.The Immunogenicity and Safety of the Live-attenuated SA 14-14-2 Japanese Encephalitis Vaccine Given with a Two-dose Primary Schedule in Children.Immunogenicity and safety of currently available Japanese encephalitis vaccines: a systematic reviewPoly-γ-glutamic acid nanoparticles and aluminum adjuvant used as an adjuvant with a single dose of Japanese encephalitis virus-like particles provide effective protection from Japanese encephalitis virus.Genetic Determinants of Japanese Encephalitis Virus Vaccine Strain SA14-14-2 That Govern Attenuation of Virulence in MiceFormalin Inactivation of Japanese Encephalitis Virus Vaccine Alters the Antigenicity and Immunogenicity of a Neutralization Epitope in Envelope Protein Domain III.Cellular Immune Responses to Live Attenuated Japanese Encephalitis (JE) Vaccine SA14-14-2 in Adults in a JE/Dengue Co-Endemic Area.Development and characterization of the replicon system of Japanese encephalitis live vaccine virus SA14-14-2.Dengue virus and Japanese encephalitis virus epidemiological shifts in Nepal: a case of opposing trends.Current use and development of vaccines for Japanese encephalitis.Aetiologies of central nervous system infections in adults in Kathmandu, Nepal: a prospective hospital-based study.Ixiaro: a new vaccine against Japanese encephalitis.IMOJEV(®): a Yellow fever virus-based novel Japanese encephalitis vaccine.Clinical development of IMOJEV ®--a recombinant Japanese encephalitis chimeric vaccine (JE-CV).Developing a dengue vaccine: progress and future challenges.A case of imported JE acquired during short travel in Vietnam. Are current recommendations about vaccination broader?Main Factors Influencing the Efficient Propagation of Virulent or Attenuated Strains of Japanese encephalitis virus in BHK-21 CellsJapanese encephalitis vaccines: Immunogenicity, protective efficacy, effectiveness, and impact on the burden of disease.Biological and genetic properties of SA₁₄-14-2, a live-attenuated Japanese encephalitis vaccine that is currently available for humans.Vaccination Policy for Japanese Encephalitis in India: Tread with Caution!Molecular characterization of Japanese encephalitis viruses circulating in pigs and mosquitoes on pig farms in the Chinese province of Henan.Immunogenicity of a live-attenuated Japanese encephalitis vaccine in children and adolescents after hematopoietic stem cell transplantation.Japanese Encephalitis Virus Generated Neurovirulence, Antigenicity, and Host Immune Responses
P2860
Q24243819-92195133-D825-47F2-9287-D70249BC42E1Q26866171-88A22C98-3640-4593-95C4-458BC1ABC3A6Q27001593-6F27C37E-B3A0-4474-8AA5-1F71CE0BBE47Q27010434-FB6607C2-1A4D-46BE-811A-E9E914894672Q34173039-08C854C7-1098-4A90-8692-4013ABC6C38EQ34694967-77BDF791-51D6-4CB5-A888-DFBF33E74137Q35140658-6A83C274-FA83-4F74-A0E5-57AA9B24AA35Q35553715-899DF0F7-125C-4AB0-A5D2-B07FC802C9D2Q35558900-1CEE814B-0749-4E60-8360-6A051B9558FEQ35666240-ED13D8AD-F010-4D73-B81F-5F3C41D84F3FQ35760499-62AA0DEB-9EFA-4966-AD3C-C4A2027F1B3FQ35818688-EF29CA34-F6D1-4EDB-8C5F-3277D268117EQ36263779-92032AF0-E219-4576-B710-EE60B08C3EC2Q36718676-B851A024-BAD8-4980-8DEC-087718A61BD8Q36743827-9924F044-4317-482A-B06C-A732CE551A31Q37032646-53FE690F-1231-4270-869D-D7FCF9F56437Q37080276-DA08A4C2-AB54-4378-B624-520B6D205095Q37622889-C2DA17E0-6C29-4619-A2F8-EB6ED7C2DAD3Q37812123-5EC22D4E-52DB-4306-A47B-A0CC8F7849ADQ38024857-D1A9F5D2-8225-4DDA-9D1A-C60FC024EFA2Q38201151-E2E97F63-9F31-497F-95AC-0A1EFAF01794Q38931702-91686E3F-2936-4C06-B561-6D5B13FE5790Q39051405-C74DEB1B-140A-475A-AF42-8CEBE7CD3F9FQ39181962-0F5DC116-7E48-4D08-8DAF-D0BE8FE73071Q39290828-74D7D8D0-0BD7-4864-935C-8A3DF5DC8695Q40395523-53C7853E-C00F-411F-9439-A516260D61E7Q42983867-206A03CF-8061-4089-9167-61A735C6E1C6Q51125991-D4837022-42DD-4B96-A542-1763175DCF82Q58999704-127D1433-2F6E-4058-8BFE-2AC9E982413F
P2860
Effect of single dose of SA 14-14-2 vaccine 1 year after immunisation in Nepalese children with Japanese encephalitis: a case-control study.
description
2005 nî lūn-bûn
@nan
2005年の論文
@ja
2005年学术文章
@wuu
2005年学术文章
@zh
2005年学术文章
@zh-cn
2005年学术文章
@zh-hans
2005年学术文章
@zh-my
2005年学术文章
@zh-sg
2005年學術文章
@yue
2005年學術文章
@zh-hant
name
Effect of single dose of SA 14 ...... halitis: a case-control study.
@en
Effect of single dose of SA 14 ...... halitis: a case-control study.
@nl
type
label
Effect of single dose of SA 14 ...... halitis: a case-control study.
@en
Effect of single dose of SA 14 ...... halitis: a case-control study.
@nl
prefLabel
Effect of single dose of SA 14 ...... halitis: a case-control study.
@en
Effect of single dose of SA 14 ...... halitis: a case-control study.
@nl
P2093
P1433
P1476
Effect of single dose of SA 14 ...... halitis: a case-control study.
@en
P2093
Durga Prasad Pradhan
Heechoul Ohrr
J B Tandan
Scott B Halstead
Sun Heang Shin
Young Mo Sohn
P304
P356
10.1016/S0140-6736(05)67567-8
P407
P577
2005-10-01T00:00:00Z